University of British Columbia
1,604
194
243
835
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.7%
139 terminated/withdrawn out of 1604 trials
85.7%
-0.9% vs industry average
10%
167 trials in Phase 3/4
11%
92 of 835 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1604)
Effects of Psilocybin on Craving in Nicotine Dependence
Role: lead
Exercise in Perimenopause to Improve Cognitive Health
Role: lead
Enhancing Physical Reserve to Promote Resilience in Physically Frail Older Adults
Role: collaborator
HCRN Endoscopic Versus Shunt Treatment of Hydrocephalus in Infants
Role: collaborator
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Role: lead
Virtual Rehabilitation for Cancer Survivors
Role: collaborator
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
Role: lead
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
Role: lead
"SCRIBBLE" Spinal Cord Injury Blood Biomarker Longitudinal Evaluation
Role: lead
"UroMonitor Trial" in Spinal Cord Injury.
Role: lead
Characterizing Hemorrhage in Acute Spinal Cord Injury With MRI
Role: lead
Clinician Practice Companion to Address Youth Substance Use
Role: collaborator
Virtual Physical Activity Seated Exercise - Phase 2
Role: lead
Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies
Role: collaborator
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
Role: collaborator
Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
Role: lead
Prospective Intestinal Ultrasound Study for Artificial Intelligence Algorithm Development
Role: lead
Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy
Role: collaborator
Preventing Falls in Older Adults With Cognitive Frailty
Role: lead
Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors
Role: lead